cilostazol has been researched along with Amentia in 5 studies
Excerpt | Relevance | Reference |
---|---|---|
"The goal of the present study was to investigate whether cilostazol use is associated with a lower risk of incident dementia in Asian patients with IHD, and whether these effects differed based on sex." | 7.88 | Effect of Cilostazol on Incident Dementia in Elderly Men and Women with Ischemic Heart Disease. ( Jung, YS; Kim, MY; Lee, S; Noh, Y; Paik, HY; Shin, S; Son, SJ, 2018) |
" We examined the potential association between the use of cilostazol, an antiplatelet agent and cyclic adenosine monophosphate phosphodiesterase 3 inhibitor, and the risk of dementia in an Asian population." | 7.85 | Cilostazol Use Is Associated with Reduced Risk of Dementia: A Nationwide Cohort Study. ( Chang, YH; Chien, CY; Tai, SY; Yang, YH, 2017) |
"In patients with mild dementia who had received donepezil and cilostazol (nā=ā34; 77." | 7.80 | Cilostazol add-on therapy in patients with mild dementia receiving donepezil: a retrospective study. ( Hattori, Y; Ihara, M; Kasahara, Y; Nishino, M; Okada, M; Saito, S; Taguchi, A; Takahashi, Y; Takata, Y; Tsuji, M; Yamamoto, Y, 2014) |
"In this randomized clinical trial, cilostazol was well tolerated, although it did not prevent cognitive decline." | 5.69 | Efficacy and Safety of Cilostazol in Mild Cognitive Impairment: A Randomized Clinical Trial. ( Aso, T; Fukushima, M; Fukuyama, H; Hattori, Y; Ihara, M; Kagimura, T; Kakuta, C; Kakuta, R; Kanki, R; Kawabata, N; Kitaguchi, H; Kojima, S; Kowa, H; Maki, T; Mizuno, T; Nagatsuka, K; Nakaoku, Y; Ohtani, R; Oishi, N; Oka, N; Saito, S; Shindo, A; Shindo, K; Sudoh, S; Suzuki, K; Tachibana, H; Taguchi, A; Takahashi, R; Takahashi, Y; Taketsuna, M; Tomimoto, H; Tonomura, S; Washida, K; Yamamoto, H; Yamamoto, K; Yamamoto, Y; Yasuno, F, 2023) |
"The goal of the present study was to investigate whether cilostazol use is associated with a lower risk of incident dementia in Asian patients with IHD, and whether these effects differed based on sex." | 3.88 | Effect of Cilostazol on Incident Dementia in Elderly Men and Women with Ischemic Heart Disease. ( Jung, YS; Kim, MY; Lee, S; Noh, Y; Paik, HY; Shin, S; Son, SJ, 2018) |
" We examined the potential association between the use of cilostazol, an antiplatelet agent and cyclic adenosine monophosphate phosphodiesterase 3 inhibitor, and the risk of dementia in an Asian population." | 3.85 | Cilostazol Use Is Associated with Reduced Risk of Dementia: A Nationwide Cohort Study. ( Chang, YH; Chien, CY; Tai, SY; Yang, YH, 2017) |
"In patients with mild dementia who had received donepezil and cilostazol (nā=ā34; 77." | 3.80 | Cilostazol add-on therapy in patients with mild dementia receiving donepezil: a retrospective study. ( Hattori, Y; Ihara, M; Kasahara, Y; Nishino, M; Okada, M; Saito, S; Taguchi, A; Takahashi, Y; Takata, Y; Tsuji, M; Yamamoto, Y, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Saito, S | 2 |
Suzuki, K | 1 |
Ohtani, R | 1 |
Maki, T | 1 |
Kowa, H | 1 |
Tachibana, H | 1 |
Washida, K | 1 |
Kawabata, N | 1 |
Mizuno, T | 1 |
Kanki, R | 1 |
Sudoh, S | 1 |
Kitaguchi, H | 1 |
Shindo, K | 1 |
Shindo, A | 1 |
Oka, N | 1 |
Yamamoto, K | 1 |
Yasuno, F | 1 |
Kakuta, C | 1 |
Kakuta, R | 1 |
Yamamoto, Y | 2 |
Hattori, Y | 2 |
Takahashi, Y | 2 |
Nakaoku, Y | 1 |
Tonomura, S | 1 |
Oishi, N | 1 |
Aso, T | 1 |
Taguchi, A | 2 |
Kagimura, T | 1 |
Kojima, S | 1 |
Taketsuna, M | 1 |
Tomimoto, H | 1 |
Takahashi, R | 1 |
Fukuyama, H | 1 |
Nagatsuka, K | 1 |
Yamamoto, H | 1 |
Fukushima, M | 1 |
Ihara, M | 2 |
Blair, GW | 1 |
Appleton, JP | 1 |
Law, ZK | 1 |
Doubal, F | 1 |
Flaherty, K | 1 |
Dooley, R | 1 |
Shuler, K | 1 |
Richardson, C | 1 |
Hamilton, I | 1 |
Shi, Y | 1 |
Stringer, M | 1 |
Boyd, J | 1 |
Thrippleton, MJ | 1 |
Sprigg, N | 1 |
Bath, PM | 1 |
Wardlaw, JM | 1 |
Kim, MY | 1 |
Noh, Y | 1 |
Son, SJ | 1 |
Shin, S | 1 |
Paik, HY | 1 |
Lee, S | 1 |
Jung, YS | 1 |
Nishino, M | 1 |
Tsuji, M | 1 |
Kasahara, Y | 1 |
Takata, Y | 1 |
Okada, M | 1 |
Tai, SY | 1 |
Chien, CY | 1 |
Chang, YH | 1 |
Yang, YH | 1 |
2 trials available for cilostazol and Amentia
Article | Year |
---|---|
Efficacy and Safety of Cilostazol in Mild Cognitive Impairment: A Randomized Clinical Trial.
Topics: Adult; Aged; Alzheimer Disease; Amyloid beta-Peptides; Cilostazol; Cognitive Dysfunction; Dementia; | 2023 |
Preventing cognitive decline and dementia from cerebral small vessel disease: The LACI-1 Trial. Protocol and statistical analysis plan of a phase IIa dose escalation trial testing tolerability, safety and effect on intermediary endpoints of isosorbide mon
Topics: Age Factors; Cerebral Small Vessel Diseases; Cilostazol; Cognition Disorders; Dementia; Double-Blind | 2018 |
3 other studies available for cilostazol and Amentia
Article | Year |
---|---|
Effect of Cilostazol on Incident Dementia in Elderly Men and Women with Ischemic Heart Disease.
Topics: Aged; Aged, 80 and over; Cilostazol; Cohort Studies; Dementia; Female; Humans; Male; Myocardial Isch | 2018 |
Cilostazol add-on therapy in patients with mild dementia receiving donepezil: a retrospective study.
Topics: Aged; Cholinesterase Inhibitors; Cilostazol; Dementia; Donepezil; Drug Therapy, Combination; Female; | 2014 |
Cilostazol Use Is Associated with Reduced Risk of Dementia: A Nationwide Cohort Study.
Topics: Adult; Aged; Aged, 80 and over; Cerebrovascular Disorders; Cilostazol; Cohort Studies; Dementia; Fem | 2017 |